Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary
暂无分享,去创建一个
D. Lipson | V. Miller | Siraj M. Ali | S. Soman | G. Palmer | N. Palma | Kai Wang | P. Stephens | D. Morosini | J. Ross | D. Dutta | Jamie O'connor | Mayur Patel | Nicholas W. Koutrelakos | J. Ross